Two decades of thyroglobulin type-1 domain research

Biological Chemistry

Volumn 388, Issue 11, 2007, Pages 1123-1130

  Mihelič, Marko ^a   Turk, Dušan ^a  

^a JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

Cysteine protease; Equistatin; IGFBP; Invariant chain; p41 fragment; Thyropin

Indexed keywords

ASPARTIC PROTEINASE; CATHEPSIN D; CATHEPSIN S; CYSTATIN; CYSTEINE PROTEINASE; EQUISTATIN; INHIBITOR PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; METALLOPROTEINASE; PAPAIN; POLYPEPTIDE; PROTEIN P41; PROTEINASE INHIBITOR; PROTEOGLYCAN; SOMATOMEDIN BINDING PROTEIN; TESTICAN; THYROGLOBULIN; THYROGLOBULIN TYPE 1; THYROPIN; UNCLASSIFIED DRUG;

CONFERENCE PAPER; ENZYME INHIBITION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEASE INHIBITORS; SEQUENCE HOMOLOGY, AMINO ACID; STRUCTURE-ACTIVITY RELATIONSHIP; THYROGLOBULIN;

EID: 35848936917     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2007.155     Document Type: Conference Paper

References (60)

1. Auerswald, E.A., Nägler, D.K., Schulze, A.J., Engh, R.A., Geneger, G., Machleidt, W., and Fritz, H. (1994). Production, inhibitory activity, folding and conformational analysis of an N-terminal and an internal deletion variant of chicken cystatin. Eur. J. Biochem. 224, 407-415.
2. Bakke, O. and Dobberstein, B. (1990). MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63, 707-716.
3. Barrett, A.J. (1981). Cystatin, the egg white inhibitor of cysteine proteinases. Methods Enzymol. 80, 771-778.
4. Barrett, A.J., Fritz, H., Grubb, A., Isemura, S., Jarvinen, M., Katunuma, N., Machleidt, W., Muller-Esterl, W., Sasaki, M., and Turk, V. (1986). Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatin. Biochem. J. 236, 312-312.
5. Bevec, T., Stoka, V., Pungercic, G., Dolenc, I., and Turk, V. (1996). Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J. Exp. Med. 183, 1331-1338.
6. Bevec, T., Stoka, V., Pungercic, G., Cazzulo, J.J., and Turk, V. (1997). A fragment of the major histocompatibility complex class II-associated p41 invariant chain inhibits cruzipain, the major cysteine proteinase from Trypanosoma cruzi. FEBS Lett. 401, 259-261.
7. Blum, J.S. and Cresswell, P. (1988). Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc. Natl. Acad. Sci. USA 185, 3975-3979.
8. Bocock, J.P., Edgell, C.J., Marr, H.S., and Erickson, A.H. (2003). Human proteoglycan testican-1 inhibits the lysosomal cysteine protease cathepsin L. Eur. J. Biochem. 270, 4008-4015.
9. Bode, W., Engh, R., Musil, D., Thiele, U., Huber, R., Karshikov, A., Brzin, J., Kos, J., and Turk, V. (1988). The 2.0 Å X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J. 7, 2593-2599.
10. Bonnet, F., Perin, J.P., Charbonnier, F., Camuzat, A., Roussel, G., Nussbaum, J.L., and Alliel, P.M. (1996). Structure and cellular distribution of mouse brain testican. Association with the postsynaptic area of hippocampus pyramidal cells. J. Biol. Chem. 271, 4373-4380.
11. Brix, K., Lemansky, P., and Herzog, V. (1996). Evidence for extracellularly acting cathepsins mediating thyroid hormone liberation in thyroid epithelial cells. Endocrinology 137, 1963-1974.
12. Brzin, J., Kopitar, M., Turk, V., and Machleidt, W. (1983). Protein inhibitors of cysteine proteinases. I. Isolation and characterization of stefin, a cytosolic protein inhibitor of cysteine proteinases from human polymorphonuclear granulocytes. Hoppe-Seyler's Z. Physiol. Chem. 364, 1475-1480.
13. Brzin, J., Popovic, T., Turk, V., Borchart, U., and Machleidt W. (1984). Human cystatin, a new protein inhibitor of cysteine proteinases. Biochem. Biophys. Res. Commun. 118, 103-109.
14. Deussing, J., Roth, W., Saftig, P., Peters, C., Ploegh, H.L., and Villadangos, J.A. (1998). Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc. Natl. Acad. Sci. USA 95, 4516-4521.
15. Estrada, S., Pavlova, A., and Björk, I. (1999). The contribution of N-terminal region residues of cystatin A (stefin A) to the affinity and kinetics of inhibition of papain. Cathepsin B and cathepsin L. Biochemistry 38, 7339-7345.
16. Fiebiger, E., Maehr, R., Villadangos, J., Weber, E., Erickson, A., Bikoff, E., Ploegh, H.L., and Lennon-Dumenil, A.M. (2002). Invariant chain controls the activity of extracellular cathepsin L. J. Exp. Med. 196, 1263-1269.
17. Fineschi, B., Arneson, L.S., Naujokas, M.F., and Miller, J. (1995). Proteolysis of major histocompatibility complex class II-associated invariant chain is regulated by the alternatively spliced gene product, p41. Proc. Natl. Acad. Sci. USA 92, 10257-10261.
18. Fineschi, B., Sakaguchi, K., Appella, E., and Miller, J. (1996). The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain. J. Immunol. 157, 3211-3215.
19. Finkenstaedt, J.T. (1957). Intracellular distribution of proteolytic enzymes in rat liver tissue. Proc. Soc. Exp. Biol. Med. 95, 302-304.
20. Fowlkes, J.L., Thrailkill, K.M., George-Nascimento, C., Rosenberg, C.K., and Serra, D.M. (1997). Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation. Endocrinology 138, 2280-2285.
21. Guncar, G., Pungercic, G., Klemencic, I., Turk, V., and Turk, D. (1999). Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S. EMBO J. 18, 793-803.
22. Headey, S.J., Leeding, K.S., Norton, R.S., and Bach, L.A. (2004). Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding. J. Mol. Endocrinol. 33, 377-386.
23. Jenko, S., Dolenc, I., Guncar, G., Dobersek, A., Podobnik, M., and Turk, D. (2003). Crystal structure of stefin A in complex with cathepsin H: N-terminal residues of inhibitors can adapt to the active sites of endo- and exopeptidases. J. Mol. Biol. 326, 875-885.
24. Jones, J.I. and Clemmons, D.R. (1995). Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16, 33-34.
25. Keilova, H. and Tomasek, V. (1975). Inhibition of cathepsin C by papain inhibitor from chicken egg white and by complex of this inhibitor with cathepsin B1. Coll. Czech. Chem. Commun. 40, 218-224.
26. Kopitar, M., Brzin, J., Zvonar, T., Locnikar, P., Kregar, I., and Turk V. (1978). Inhibition studies of an intracellular inhibitor on thiol proteinases. FEBS Lett. 91, 355-359.
27. Lenarcic, B. and Bevec, T. (1998). Thyropins - new structurally related proteinase inhibitors. Biol. Chem. 379, 105-111.
28. Lenarcic, B. and Turk, V. (1999). Thyroglobulin type-1 domains in equistatin inhibit both papain-like cysteine proteinases and cathepsin D. J. Biol. Chem. 274, 563-566.
29. Lenarcic, B., Ritonja, A., Strukelj, B., Turk, B., and Turk, V. (1997). Equistatin, a new inhibitor of cysteine proteinases from Actinia equina, is structurally related to thyroglobulin type-1 domain. J. Biol. Chem. 272, 13899-13903.
30. Lenarcic, B., Krishnan, G., Borukhovich, R., Ruck, B., Turk, V., and Moczydlowski, E. (2000). Saxiphilin, a saxitoxin-binding protein with two thyroglobulin type 1 domains, is an inhibitor of papain-like cysteine proteinases. J. Biol. Chem. 275, 15572-15577.
31. Lennon-Dumenil, A.M., Roberts, R.A., Valentijn, K., Driessen, C., Overkleeft, H.S., Erickson, A., Peters, P.J., Bikoff, E., Ploegh, H.L., and Wolf Bryant, P. (2001). The p41 isoform of invariant chain is a chaperone for cathepsin L. EMBO J. 20, 4055-4064.
32. Lotteau, V., Teyton, L., Peleraux, A., Nilsson, T., Karlsson, L., Schmid, S.L., Quaranta, V., and Peterson, P.A. (1990). Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348, 600-605.
33. Machleidt, W., Borchart, U., Fritz, H., Brzin, J., Ritonja, A., and Turk, V. (1983). Protein inhibitors of cysteine proteinases. II. Primary structure of stefin, a cytosolic protein inhibitor of cysteine proteinases from human polymorphonuclear granulocytes. Hoppe-Seyler's Z. Physiol. Chem. 364, 1481-1486.
34. Malthiery, Y., Marriq, C., Berge-Lefranc, J.L., Franc, J.L., Henry, M., Lejeune, P.J., Ruf, J., and Lissitzky, S. (1989). Thyroglobulin structure and function: recent advances. Biochimie 71, 195-209.
35. Manoury, B., Mazzeo, D., Li, D.N., Billson, J., Loak, K., Benaroch, P., and Watts, C. (2003). Asparagine endopeptidase can initiate the removal of the MHC class II invariant chain chaperone. Immunity 18, 489-498.
36. Mason, R.W., Johnson, D.A., Barrett, A.J., and Chapman, H.A. (1986). Elastinolytic activity of human cathepsin L. Biochem. J. 233, 925-927.
37. Meh, P., Pavsic, M., Turk, V., Baici, A., and Lenarcic, B. (2005). Dual concentration-dependent activity of thyroglobulin type-1 domain of testican: specific inhibitor and substrate of cathepsin L. Biol. Chem. 386, 75-83.
38. Mihelic, M., Teuscher, C., Turk, V., and Turk, D. (2006). Mouse stefins A1 and A2 (Stfa1 and Stfa2) differentiate between papain-like endo- and exopeptidases. FEBS Lett. 580, 4195-4199.
39. Molina, F., Bouanani, M., Pau, B., and Granier, C. (1996). Characterization of the type-1 repeat from thyroglobulin, a cysteine-rich module found in proteins from different families. Eur. J. Biochem. 240, 125-133.
40. Nakada, M., Yamada, A., Takino, T., Miyamori, H., Takahashi, T., Yamashita, J., and Sato, H. (2001). Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes. Cancer Res. 61, 8896-8902.
41. Nakagawa, T., Roth, W., Wong, P., Nelson, A., Farr, A., Deussing, J., Villadangos, J.A., Ploegh, H., Peters, C., and Rudensky, A.Y. (1998). Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 280, 450-453.
42. Ogrinc, T., Dolenc, I., Ritonja, A., and Turk, V. (1993). Purification of the complex of cathepsin L and MHC class II associated invariant chain fragment from human kidney. FEBS Lett. 336, 555-559.
43. Pavlova, A., Mort, J.S., Abrahamson, M., and Björk, I. (2000). Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration by release of loop anchoring through mutation of His110. FEBS Lett. 487, 156-160.
44. Pungercic, G., Dolenc, I., Dolinar, M., Bevec, T., Jenko, S., Kolaric, S., and Turk, V. (2002). Individual recombinant thyroglobulin type-1 domains are substrates for lysosomal cysteine proteinases. Biol. Chem. 383, 1809-1812.
45. Riese, R.J., Wolf, P.R., Bromme, D., Natkin, L.R., Villadangos, J.A., Ploegh, H.L., and Chapman, H.A. (1996). Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 4, 357-366.
46. Riese, R.J., Mitchell, R.N., Villadangos, J.A., Shi, G.P., Palmer, J.T., Karp, E.R., De Sanctis, G.T., Ploegh, H.L., and Chapman, H. (1998). Cathepsin S activity regulates antigen presentation and immunity. J. Clin. Invest. 101, 2351-2363.
47. Rodriguez, G.M. and Diment, S. (1995). Destructive proteolysis by cysteine proteases in antigen presentation of ovalbumin. Eur. J. Immunol. 25, 1823-1827.
48. Sen, L.C. and Whitaker, J.R. (1973). Some properties of a ficinpapain inhibitor from avian egg white. Arch. Biochem. Biophys. 158, 623-632.
49. Sitar, T., Popowicz, G.M., Siwanowicz, I., Huber, R., and Holak, T.A. (2006). Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins. Proc. Natl. Acad. Sci. USA 103, 13028-13033.
50. Strubin, M., Berte, C., and Mach, B. (1986). Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain. EMBO J. 5, 3483-3488.
51. Stubbs, M.T., Laber, B., Bode, W., Huber, R., Jerala, R., Lenarcic, B., and Turk, V. (1990). The refined 2.4 A° X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. EMBO J. 9, 1939-1947.
52. Tepel, C., Bromme, D., Herzog, V., and Brix, K. (2000). Cathepsin K in thyroid epithelial cells: sequence, localization and possible function in extracellular proteolysis of thyroglobulin. J. Cell Sci. 24, 4487-4498.
53. Tolosa, E., Li, W., Yasuda, Y., Wienhold, W., Denzin, L.K., Lautwein, A., Driessen, C., Schnorrer, P., Weber, E., Stevanovic, S., et al. (2003). Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis. J. Clin. Invest. 112, 517-526.
54. Turk, B., Turk, D., and Salvesen, G.S. (2002). Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Curr. Pharm. Des. 8, 1623-1637.
55. Turk, D. (1992). Weiterentwicklung eines Programmes fur Molekulgraphik und Elektronendichte-manipulation und seine Anwendungen auf verschiedene Protein-strukturaufkläurungen. Ph.D. Thesis, Technische Universitàt Mùnchen, Germany.
56. Turk, V. and Bode, W. (1991). The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett. 285, 213-219.
57. Turk, V., Brzin, J., Longer, M., Ritonja, A., Eropkin, M., Borchart, U., and Machleidt, W. (1983). Protein inhibitors of cysteine proteinases. III. Amino acid sequence of cystatin from chicken egg white. Hoppe-Seyler's Z. Physiol. Chem. 364, 1487-1496.
58. Vannahme, C., Schubel, S., Herud, M., Gosling, S., Hulsmann, H., Paulsson, M., Hartmann, U., and Maurer, P. (1999). Molecular cloning of testican-2: defining a novel calcium-binding proteoglycan family expressed in brain. J. Neurochem. 73, 12-20.
59. Yamashita, M. and Konagaya, S. (1991). Cysteine protease inhibitor in egg of chum salmon. J. Biochem. 110, 762-766.
60. Yamashita, M. and Konagaya, S. (1996). A novel cysteine protease inhibitor of the egg of chum salmon, containing a cysteine-rich thyroglobulin-like motif. J. Biol. Chem. 271, 1282-1284.